Lukyanenko et al. show that a chimeric protein containing two PKCαC2 domains and the C2A domain of dysferlin localizes to triad junctions (white arrowheads) in dysferlin-deficient myofibers. The C2A domain supports both normal Ca²⁺ signaling and membrane repair after injury, suggesting an alternative gene therapy approach for dysferlin-associated myopathies.